This is a heart condition that can develop in people with diabetes. It involves changes in the heart muscle, often leading to heart failure. It's caused by damage to the heart's blood vessels and the way the heart uses sugar, which can happen because of diabetes.
Every report comes from a Lived member, sent anonymously.
Have you tried Farxiga (Dapagliflozin) for Diabetic Cardiomyopathy?
Diabetic cardiomyopathy is damage to the heart muscle linked to diabetes itself, rather than to the more familiar causes of heart trouble such as blocked heart arteries, high blood pressure or faulty valves. Over years, the main pumping chamber (the left ventricle) becomes thicker and stiffer, so it relaxes and fills less easily between beats. Later, in some people, the muscle also loses pumping strength. In its early stages it usually causes no symptoms and is found only on heart tests. It matters because it can progress to heart failure, a condition in which the heart cannot keep up with the body's needs, causing breathlessness, tiredness and fluid buildup. Heart failure is a common and often underrecognized complication of diabetes, and sometimes it is the first sign of heart disease a person with diabetes has.
Long-term high blood sugar and insulin resistance (when the body's cells respond poorly to insulin) are central to the condition. Over time they change how heart muscle cells use fuel and lead to inflammation, scarring (fibrosis) and stiffening of the heart wall. Studies link higher average blood sugar, measured by the A1C test, to a higher risk of heart failure. Obesity, physical inactivity and smoking add to the risk, and so does chronic kidney disease. Women with diabetes appear to carry a higher excess risk than men. Most research involves type 2 diabetes; whether the same process occurs in type 1 diabetes is less well established. In real life, many people with diabetes also have high blood pressure or narrowed arteries, which strain the heart in their own ways, so these factors often act together.
There is no single test for diabetic cardiomyopathy, and experts have not agreed on one definition. It is identified by finding heart muscle changes in someone with diabetes and then ruling out other explanations, especially coronary artery disease (narrowed heart arteries), high blood pressure and valve disease. The American Diabetes Association suggests that adults with diabetes consider a blood test for a natriuretic peptide (BNP or NT-proBNP), a hormone the heart releases when it is under strain. If the level is raised, an echocardiogram, an ultrasound of the heart, is recommended. The echocardiogram shows how thick the heart walls are, how well the heart relaxes and fills, and its ejection fraction: the percentage of blood the left ventricle pushes out with each beat. An ejection fraction of about 50% or higher is considered preserved; 40% or lower is reduced. Diabetic cardiomyopathy often begins with problems in relaxation while the ejection fraction is still normal, which is why a normal ejection fraction does not rule it out. If heart failure is found, doctors usually look for blocked arteries with a stress test or other imaging. Cardiac MRI (magnetic resonance imaging) and specialized echocardiogram measurements can detect earlier changes, but how they should guide treatment is still being studied.
No medicine is approved specifically for diabetic cardiomyopathy. Treatment aims to slow damage to the heart muscle and, if heart failure develops, to relieve symptoms and lower the chance of hospital stays. The foundation is good long-term control of blood sugar, blood pressure and cholesterol, along with regular aerobic activity, weight management when needed and not smoking. Some diabetes medicines also protect the heart. SGLT2 (sodium-glucose cotransporter 2) inhibitors, such as empagliflozin (Jardiance) and dapagliflozin (Farxiga), lower blood sugar by having the kidneys release extra sugar into the urine, and in people with type 2 diabetes and heart failure they reduce the risk of worsening heart failure and death from heart causes. They can occasionally lead to a dangerous acid buildup called diabetic ketoacidosis, even when blood sugar is normal or only mildly raised, so people taking them should learn its signs and how to check ketones. For people with type 2 diabetes, obesity and heart failure with preserved ejection fraction, weekly injectable diabetes and weight-loss medicines that act on the GLP-1 (glucagon-like peptide 1) hormone pathway, such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), can also reduce heart failure symptoms and events. When testing shows heart changes without symptoms, guidelines recommend an ACE (angiotensin-converting enzyme) inhibitor or angiotensin receptor blocker (blood pressure medicines that ease strain on the heart) and a beta blocker, which slows and steadies the heartbeat, to reduce the chance of progressing to heart failure. Once heart failure is present, standard heart failure treatment applies, including diuretics (water pills) to clear extra fluid. Some diabetes medicines are a poor fit: pioglitazone (Actos) can cause fluid retention and should be avoided in heart failure.
Diabetic cardiomyopathy usually develops slowly, over years. Many people live for a long time with early changes that cause no symptoms, and catching it at that stage gives the best chance to slow it down. The course varies a great deal, depending on blood sugar control, other heart risks and how consistently treatment is followed. If heart failure develops, daily life often involves taking several medicines, limiting salt, staying physically active within a plan from the care team, and weighing yourself regularly, because a quick gain can be the first sign of fluid building up. Follow-up visits typically include blood tests for kidney function and potassium, which several of these medicines affect, and repeat heart scans when symptoms change. Diabetes and heart care work best when the primary care clinician, diabetes team and cardiologist coordinate the plan.
If you have diabetes, raise it with your clinician if you notice new shortness of breath with ordinary activity such as climbing stairs, swelling in the ankles, legs or belly, needing extra pillows to breathe when lying flat, or tiredness that rest doesn't relieve. If you already have heart failure, contact your care team when you gain weight quickly (more than 2 to 3 pounds in a day or 5 pounds in a week, unless your team sets a different limit), the swelling or cough increases, or you feel weaker than usual, since these can mean fluid is building up. Call 911 if you faint, have severe chest pain, or have severe or sudden trouble breathing, especially at rest or with a frothy, pink-tinged cough. Get emergency care for a fast, irregular heartbeat, especially with other symptoms.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Diabetic Cardiomyopathy is like, what's helped you, or ask the community a question.